Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Zillow Faces Weak Agent Feedback, Lower-End Demand, RBC Says

Zillow Faces Weak Agent Feedback, Lower-End Demand, RBC Says

MT newswireMT newswire2026/11/03 15:21
11:21 AM EST, 11/03/2026 (MT Newswires) -- Zillow (ZG) faces challenges from weaker buyer demand, deteriorating lead quality and friction in its Preferred transition, with recent agent checks largely negative, RBC Capital Markets said in a note emailed Tuesday. The firm believes Q3 results could come in toward the lower end of guidance. The company is slated to release its quarterly results on Wednesday. The brokerage said buyer intent weakened amid affordability and interest-rate pressures, particularly at the lower end. Feedback on Zillow Home Loans was mixed, with concerns over underwriting and product options offset by positive comments on responsiveness and preapproval speed. RBC noted that rental lead substitution could weigh on demand, while the accelerated shift to Zillow Preferred faced transition challenges. Zillow visits and monthly active users also declined for a second consecutive quarter in Q2, with further weakness possible in Q3, according to the note. The analyst lowered its Q4 revenue and adjusted earnings before interest, taxes, depreciation and amortization estimates to $688 million and $175 million, respectively. The firm also noted the chances of Google exploring its own portal-type of solution as a negative catalyst risk. RBC maintained its outperform rating on the stock but lowered its price target to $45 from $55. Price: 31.98, Change: -0.92, Percent Change: -2.80
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Dental treatment company vVardis has announced the terms for its $214 million US IPO.

智通财经•2026/11/09 06:41
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

智通财经•2026/11/09 06:41
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss